Phase 4 Cardiogenic Shock Clinical Trials
4 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–4 of 4 trials
Recruiting
Phase 4
Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure
Heart FailureCardiogenic ShockKetone Body Metabolism+2 more
Institute for Clinical and Experimental Medicine12 enrolled1 locationNCT07527156
Recruiting
Phase 4
Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Target in Patients With Cardiogenic Shock From Acute Myocardial Infarction
Myocardial InfarctionCardiogenic Shock
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)776 enrolled1 locationNCT05168462
Recruiting
Phase 4
Accelerated vs. Standard Continuous Renal Replacement Therapy for Patients With Cardiogenic Shock Undergoing Veno-arterial ExtraCorporeal Membrane Oxygenator
Acute Kidney InjuryCardiogenic Shock
Samsung Medical Center408 enrolled2 locationsNCT06696235
Recruiting
Phase 4
Revascularization Strategy of Multivessel Disease for Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock Undergoing Veno-arterial Extracorporeal Membrane Oxygenator
Cardiogenic ShockAcute Myocardial InfarctionExtracorporeal Membrane Oxygenation+1 more
Samsung Medical Center560 enrolled1 locationNCT05527717